オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sotalol hydrochloride, quantity: 80 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; methylcellulose; dextrates; magnesium stearate; indigo carmine aluminium lake - prevention and treatment of supraventricular and ventricular arrhythmias.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sotalol hydrochloride, quantity: 160 mg - tablet, uncoated - excipient ingredients: magnesium stearate; methylcellulose; dextrates; colloidal anhydrous silica; indigo carmine aluminium lake - prevention and treatment of supraventricular and ventricular arrhythmias.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 300 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections - sodium ascorbate solution injection for intravenous infusion is indicated for the treatment of vitamin c deficiency when oral treatment is not feasible.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 300 g/l - injection, intravenous infusion - excipient ingredients: water for injections - sodium ascorbate solution injection for intravenous infusion is indicated for the treatment of vitamin c deficiency when oral treatment is not feasible.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - voriconazole -

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - voriconazole -

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 90 g/l - injection, intravenous infusion - excipient ingredients: water for injections - sodium ascorbate injections are indicated for the treatment of vitamin c deficiency when oral treatment is not feasible

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 150 g/l - injection, intravenous infusion - excipient ingredients: water for injections - sodium ascorbate solution injection for intravenous infusion is indicated for the treatment of vitamin c deficiency when oral treatment is not feasible.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 300 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections - sodium ascorbate solution injection for intravenous infusion is indicated for the treatment of vitamin c deficiency when oral treatment is not feasible.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 150 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections - sodium ascorbate solution injection for intravenous infusion is indicated for the treatment of vitamin c deficiency when oral treatment is not feasible.